BACKGROUND
The JenaValve Trilogy Transcatheter Heart Valve System (Trilogy) is a CE-marked transcatheter aortic valve replacement device designed for the treatment of symptomatic aortic regurgitation. Despite its unique indication, data from large cohorts remain limited. This study aimed to evaluate procedural characte...
H. Wienemann, Sara Yousefzada, M. Rogmann et al.· Circulation. Cardiovascular...· 0 citations
ABSTRACT Background Aortic regurgitation (AR) is a frequent and clinically relevant complication in patients with left ventricular assist devices (LVAD), impairing circulatory support and worsening outcomes. Surgical aortic valve replacement often carries prohibitive risk in this population, while conventional transcat...
H. Hinkov, Sara Yousefzada, I. Just et al.· Artificial Organs· 0 citations
P Pipelines combining expert-curated knowledge injection, LLM-based clinical data extraction, and deterministic score calculation enable accurate and scalable cardiovascular risk score computation from unstructured real-world clinical data, outperforming physician-documented scores.
T. Roeschl, Marie Hoffmann, A. Unbehaun et al.· European Heart Journal - Dig...· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.